Digitisation | November 03, 2023
Can-Fite signs agreement with Collaborations Pharmaceuticals to develop anti-cancer drugs using AI
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
RHTC will address a long-standing healthcare access issue for all the local population
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Profit after tax (before exceptional items) up 23% to Rs 215 crores
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Subscribe To Our Newsletter & Stay Updated
